We report three new mutations in PTEN,
The term "Bannayan-Riley-Ruvalcaba" syndrome (BRR) (MIM 153480) has been proposed' to encompass three autosomal dominant conditions previously described as separate entities: Bannayan-Zonana, RileySmith, and Ruvalcaba-Myhre syndromes. Typical clinical features of BRR include macrocephaly, multiple lipomas, intestinal hamartomatous polyps, vascular malformations, and pigmented macules of the penis. At least half of the patients affected with BRR have hypotonia, delayed psychomotor development, mild to severe mental deficiency, and seizures.' BRR exhibits a number of clinical similarities to Cowden disease (CD), a dominant cancer predisposing syndrome, also known as multiple hamartoma syndrome. CD is characterised by mucocutaneous findings that include facial trichilemmomas, oral papillomatosis, and acral/palmoplantar keratosis. Patients with CD can also exhibit hamartomas in several organs and are at an increased risk for both thyroid and breast cancers, breast cancer developing in 20-25% of women and thyroid cancer in 3-10% of all affected subjects.3 In addition, about 25% of CD patients have lipoma and macrocephaly.2 In contrast, hyperpigmented macules of the penis are rare in subjects with CD, having only been reported twice.'
Given the clinical similarities between these disorders, the idea of a possible common genetic pathogenesis between BRR and CD was previously put forward. 4 Recently, mutations in the putative tumour suppressor gene PTEN, encoding a protein tyrosine phosphatase, were detected in patients with CD.5 6 Subsequently, Marsh et aft discovered germline mutations in PTEN in six BRR patients from two unrelated families, suggesting that CD and BRR are indeed allelic disorders.
In this paper, we report three new mutations in PTEN in five subjects with BRR from three unrelated, European families, confirming that mutations in PTEN result in both CD and BRR phenotypes.
Patients, materials, and methods
The proband (III.3, fig 1) , a 17 year old French male, was mildly mentally retarded and had enuresis and encopresis since early childhood.
At the age of 15, a fibroscopic examination of the upper gastrointestinal tract showed multiple 0.5 to 5 mm polyps in the stomach which were hamartomatous on pathological examination. Colonoscopic examination was normal. At 17 years of age, physical examination showed macrocephaly (occipitofrontal circumference (OFC) 64 cm, >97th centile) and a vascular malformation of the right buttock, which on arteriography was shown to be a haemangioma. Mucocutaneous findings included multiple oral papillomas, 2 small cafe au lait macules, and multiple 1 to 5 mm pigmented macules on the glans and the shaft of the penis. A colonoscopic examination showed about 10 1 to 5 mm hamartomatous polyps in the rectum. Thyroid ultrasonography and scintigraphy were normal.
Patient 2
The father of the proband (I1.2, fig 1) had a history of mild mental retardation, psychiatric disorder, and alcoholism. At the age of 41, he was obese and had an adenoid facies with macrocephaly (OFC 66 cm, >97th centile). Mucocutaneous examination showed multiple oral papillomas, multiple facial papules, palmar keratosis, and skin tags in the axillae and the right flank. He had no pigmented macules of the genitalia. A colonoscopic examination showed multiple polyps in the colon and in the rectosigmoid, which were found to be ganglioneuromatous on histological examination. There was no palpable thyroid tumour but scintigraphy showed a large multinodular endothoracic goitre. Hormonal testing showed an abnormal level of calcitonin after stimulation with pentagastrin (205 ng/l at five and 10 minutes, normal <10 ng/l), suggesting medullary carcinoma of the thyroid. The gland was surgically removed and histological examination showed features of both benign adenoma and C cell hyperplasia without any signs of medullary carcinoma. The subject's pentagastrin stimulated level of calcitonin was normal six months after the removal of the thyroid.
Patient 3
The paternal uncle of the proband (II. fig 2) .
In family C, a heterozygous mutation in exon 7, 1444 C-*T, was found in the proband. This mutation results in a premature stop at codon 214 (Q214X) (fig 2) . Neither parent had evidence of the mutation, suggesting that the mutation in PTEN was de novo (the paternity was confirmed by DNA polymorphism analysis).
Discussion
In this paper we present three previously undescribed mutations of the putative tumour suppressor gene PTEN, the gene responsible for CD, in patients with the BRR phenotype, confirming that these diseases are allelic.'
In family A, the diagnosis of BRR was made in. 111.6 and 11.4, given mild mental retardation, macrocephaly, vascular malformations, intestinal polyposis, and pigmented macules of the penis. However, the mucocutaneous features and the thyroid involvement of patient 11.2 were more suggestive of GD. In conclusion, the three new mutations found in PTEN in patients with BRR syndrome confirm that CD and BRR, long considered as separate entities, are allelic. Furthermore, as the features of both diseases can in childhood be limited to macrosomia/ macrocephaly with or without mental retardation, it now seems important to screen patients presenting with these clinical signs for PTEN mutations. Finally, as one affected subject from a family reported in this paper died of breast and endometrial cancer, it may be warranted to consider BRR as a disorder also predisposing to cancer and to follow these patients accordingly in adulthood.
Note added in proof Since the submission of this manuscript, we have studied another patient affected with BRR. Briefly, this 2 year old boy had mild psychomotor retardation and macrocephaly (55 cm, +4.5 SD). He had two subcutaneous lipomas but no pigmented macule of the penis. Molecular analysis showed a de novo mutation in exon 7 of PTEN (1570G-*T) resulting in a codon stop at position 256 (E256X).
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